I took my loss on NNVC and would never buy it again. They can't get anywhere near clinical trials. NNVC started before CTIX, and they haven't gotten one single clinical trial going -- it's always "we need more animal testing" or "we are focusing on disease XXX" and then they change the focus.
Utterly different story than CTIX. You might also wonder why it was the Leo Ehrlich left NNVC after a year, and says he has not had contact with them since, except to say hello when they ran into each other at a conference.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links